Cargando…
The Reduction of Visceral Adipose Tissue after Roux-en-Y Gastric Bypass Is more Pronounced in Patients with Impaired Glucose Metabolism
PURPOSE: Visceral adipose tissue (VAT) is associated with cardiometabolic risk factors and insulin resistance. The physiological mechanisms underlying the benefits of Roux-en-Y gastric bypass surgery (RYGB) on glucose metabolism remain incompletely understood. The impact of RYGB on VAT was assessed...
Autores principales: | Favre, Lucie, Marino, Laura, Roth, Aline, Acierno, James, Hans, Didier, Demartines, Nicolas, Pitteloud, Nelly, Suter, Michel, Collet, Tinh-Hai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223744/ https://www.ncbi.nlm.nih.gov/pubmed/30109666 http://dx.doi.org/10.1007/s11695-018-3455-x |
Ejemplares similares
-
Early Bleeding After Laparoscopic Roux-en-Y Gastric Bypass: Incidence, Risk Factors, and Management — a 21-Year Experience
por: Odovic, Maja, et al.
Publicado: (2022) -
The Influence of a Roux-en-Y Gastric Bypass on Plasma Concentrations of Antidepressants
por: Garin, Paul, et al.
Publicado: (2023) -
How Sustained is Roux-en-Y Gastric Bypass Long-term Efficacy?: Roux-en-Y Gastric Bypass efficacy
por: Guimarães, Marta, et al.
Publicado: (2021) -
The Jejunojejunostomy: an Achilles Heel of the Roux-en-Y Gastric Bypass Construction
por: Hedberg, Suzanne, et al.
Publicado: (2021) -
One Anastomosis Gastric Bypass Versus Long Biliopancreatic Limb Roux-en-Y Gastric Bypass
por: Ibrahim, Mohamed Y., et al.
Publicado: (2022)